Form 4 for TDOC Teladoc Health, Inc.
Accepted 2023-11-20 00:00:00 ET · period of report 2023-11-17 · accession 0001477449-23-000084 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-20 | 2023-11-17 | TDOC | Daniel Karen L | Dir | M - OptEx | — | +436 | 51.1K | +0.9% | — |
| D | 2023-11-20 | 2023-11-17 | TDOC | Daniel Karen L | Dir | M - OptEx | $0.00 | -436 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-17 | M | A | 436 | — | 51,068 | D | — | — | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Units | 2023-11-17 | M | D | 436 | $0.00 | 0 | D | — · — to — | 436 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. (F3) The restricted stock units vest in three substantially equal annual installments beginning November 19, 2021. |